Cargando…
581. Do Comorbidities and Polypharmacy Lead to Virologic Failure in All Populations Living with HIV?
BACKGROUND: As HIV antiretroviral therapy (ART) becomes increasingly more simplified and effective, many patients living with HIV benefit with reduced ART pill burden and longer life expectancy. As this patient population ages, the prevalence of comorbidities increases the likelihood of polypharmacy...
Autores principales: | Jimenez, Humberto, Stevens, Ty, Suh, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253642/ http://dx.doi.org/10.1093/ofid/ofy210.589 |
Ejemplares similares
-
936. Evaluating the Impact of Polypharmacy on Virologic Success in People with HIV
por: Jimenez, Humberto R, et al.
Publicado: (2020) -
581 Chronic Urticaria and Infections
por: Aguilar, Nadia, et al.
Publicado: (2012) -
Higher Risks of Virologic Failure and All-Cause Deaths Among Older People Living with HIV in Chongqing, China
por: Wu, Guohui, et al.
Publicado: (2019) -
SUN-581 An Unusual Presentation of Hypothyroidism
por: Alim, Hussam, et al.
Publicado: (2019) -
1575. Comparison of virologic suppression rates pre-, intra- and postpartum in women with HIV in an underserved US community
por: Gerdes, Elise N, et al.
Publicado: (2023)